Evidence map›Paper›PMID 23498975›Full record

ArticleNeuron2013

Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels.

Fernando Bartolome, Hsiu-Chuan Wu, Victoria S Burchell, Elisavet Preza, Selina Wray, Colin J Mahoney, Nick C Fox, Andrea Calvo, Antonio Canosa, Cristina Moglia and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Neuron, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 152 citations in OpenAlex.

  1. The NORAD-Pumilio regulatory axis in the evolution of inclusion body myositis.Journal of neuropathology and experimental neurology · 2026
    Article
  2. Review
  3. Review
  4. Function and regulation of the mitochondrial stress response.Nature structural & molecular biology · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Targeting mitophagy in neurodegenerative diseases.Nature reviews. Drug discovery · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Fernando BartolomeDepartment of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.
Hsiu-Chuan Wu
Victoria S Burchell
Elisavet Preza
Selina Wray
Colin J Mahoney
Nick C Fox
Andrea Calvo
Antonio Canosa
Cristina Moglia
Jessica Mandrioli
Adriano Chiò
Richard W Orrell
Henry Houlden
John Hardy
Andrey Y Abramov
Helene Plun-Favreau
University College London · GBNational Hospital for Neurology and Neurosurgery · GBUniversity of Turin · ITRoland Hill (United Kingdom) · GBUK Dementia Research Institute · GBUniversity of Modena and Reggio Emilia · IT

Funding

Medical Research Council G0700183Medical Research Council G0701075Medical Research Council G0802760Medical Research Council G1001253Medical Research Council G108/638Medical Research Council MC_G1000735Medical Research Council MR/J004758/1Medical Research Council MR/K000608/1Wellcome Trust 089698
6 · The paper itself

Abstract

Valosin-containing protein (VCP) is a highly expressed member of the type II AAA+ ATPase family. VCP mutations are the cause of inclusion body myopathy, Paget's disease of the bone, and frontotemporal dementia (IBMPFD) and they account for 1%-2% of familial amyotrophic lateral sclerosis (ALS). Using fibroblasts from patients carrying three independent pathogenic mutations in the VCP gene, we show that VCP deficiency causes profound mitochondrial uncoupling leading to decreased mitochondrial membrane potential and increased mitochondrial oxygen consumption. This mitochondrial uncoupling results in a significant reduction of cellular ATP production. Decreased ATP levels in VCP-deficient cells lower their energy capacity, making them more vulnerable to high energy-demanding processes such as ischemia. Our findings propose a mechanism by which pathogenic VCP mutations lead to cell death.

Indexed as

Adenosine TriphosphatasesAdenosine TriphosphateAdultAgedAnalysis of VarianceAnimalsAnimals, NewbornCase-Control StudiesCell Cycle ProteinsCells, CulturedCerebral CortexFamily HealthFemaleFibroblastsFrontotemporal DementiaHumansAdenosine TriphosphatasesAdenosine TriphosphateCell Cycle ProteinsLuminescent ProteinsMagnesiumNADRNA, Small InterferingValosin Containing ProteinVCP protein, humanVcp protein, mouse

Identifiers

PMID23498975
PMCPMC3843114
OpenAlexW2143472860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.